HEADER HYDROLASE 05-FEB-16 5I12 TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-9 IN COMPLEX WITH A TITLE 2 SELECTIVE SUGAR-CONJUGATED ARYLSULFONAMIDE CARBOXYLATE WATER-SOLUBLE TITLE 3 INHIBITOR (DC27). COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX METALLOPROTEINASE-9,MATRIX METALLOPROTEINASE-9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 113-216,UNP RESIDUES 392-444,UNP RESIDUES 113- COMPND 5 216,UNP RESIDUES 392-444; COMPND 6 SYNONYM: MMP-9,92 KDA GELATINASE,92 KDA TYPE IV COLLAGENASE, COMPND 7 GELATINASE B,GELB,MMP-9,92 KDA GELATINASE,92 KDA TYPE IV COLLAGENASE, COMPND 8 GELATINASE B,GELB; COMPND 9 EC: 3.4.24.35,3.4.24.35; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: MMP-9 CATALYTIC DOMAIN WITHOUT FIBRONECTIN TYPE II COMPND 12 DOMAINS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: NEUTROPHIL; SOURCE 6 GENE: MMP9, CLG4B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, GLYCOCONJUGATE, METALLOPROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,L.ROSALIA,D.CUFFARO,L.TEPSHI,L.CICCONE,A.ROSSELLO REVDAT 4 10-JAN-24 5I12 1 LINK REVDAT 3 17-AUG-16 5I12 1 JRNL REVDAT 2 13-JUL-16 5I12 1 JRNL REVDAT 1 06-JUL-16 5I12 0 JRNL AUTH E.NUTI,D.CUFFARO,F.D'ANDREA,L.ROSALIA,L.TEPSHI,M.FABBI, JRNL AUTH 2 G.CARBOTTI,S.FERRINI,S.SANTAMARIA,C.CAMODECA,L.CICCONE, JRNL AUTH 3 E.ORLANDINI,S.NENCETTI,E.A.STURA,V.DIVE,A.ROSSELLO JRNL TITL SUGAR-BASED ARYLSULFONAMIDE CARBOXYLATES AS SELECTIVE AND JRNL TITL 2 WATER-SOLUBLE MATRIX METALLOPROTEINASE-12 INHIBITORS. JRNL REF CHEMMEDCHEM V. 11 1626 2016 JRNL REFN ESSN 1860-7187 JRNL PMID 27356908 JRNL DOI 10.1002/CMDC.201600235 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 20929 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2679 - 3.0390 1.00 3049 161 0.1643 0.2094 REMARK 3 2 3.0390 - 2.4123 1.00 2898 152 0.1861 0.2224 REMARK 3 3 2.4123 - 2.1075 1.00 2824 149 0.1727 0.2180 REMARK 3 4 2.1075 - 1.9148 1.00 2818 148 0.1866 0.2306 REMARK 3 5 1.9148 - 1.7776 1.00 2792 147 0.2241 0.2752 REMARK 3 6 1.7776 - 1.6728 1.00 2784 147 0.2879 0.2818 REMARK 3 7 1.6728 - 1.5890 0.98 2717 143 0.3491 0.3754 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1444 REMARK 3 ANGLE : 1.033 1974 REMARK 3 CHIRALITY : 0.044 195 REMARK 3 PLANARITY : 0.006 263 REMARK 3 DIHEDRAL : 15.884 504 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 19.9460 -9.1917 14.9787 REMARK 3 T TENSOR REMARK 3 T11: 0.1031 T22: 0.2978 REMARK 3 T33: 0.1831 T12: 0.0322 REMARK 3 T13: 0.0054 T23: -0.0349 REMARK 3 L TENSOR REMARK 3 L11: 1.8176 L22: 2.6271 REMARK 3 L33: 4.3467 L12: 0.4040 REMARK 3 L13: 0.2226 L23: 1.4350 REMARK 3 S TENSOR REMARK 3 S11: -0.0815 S12: -0.0565 S13: 0.0166 REMARK 3 S21: 0.0877 S22: 0.2506 S23: -0.0928 REMARK 3 S31: 0.1737 S32: 0.5501 S33: -0.0924 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5I12 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000218078. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7-7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8729 REMARK 200 MONOCHROMATOR : CHANNEL CUT SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20981 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : 0.11100 REMARK 200 FOR THE DATA SET : 15.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 13.70 REMARK 200 R MERGE FOR SHELL (I) : 1.63000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.650 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4H3X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 415.2 MICRO-M MMP9 REMARK 280 WT + 0.120 M ACETOHYDROXAMIC ACID IN 20 MM TRIS PH 7.0 WITH REMARK 280 0.001 M INHIBITOR DC27 AND 10% DMSO. PRECIPITANT: 40% MPEG 5K ; REMARK 280 0.1 M BICINE ; PH 7.25 SITTING DROPS OF 1 MICRO-L PROTEIN REMARK 280 SOLUTION AND 1 MICRO-L PRECIPITANT SOLUTION. CRYOPROTECTANT:_40% REMARK 280 CRYOMIX CM2 (25 % DI-ETHYLENE GLYCOL + 25 % GLYCEROL + 25 % 1,2- REMARK 280 PROPANEDIOL), 10% PEG 10K, 200 MILLI-M NACL, 100 MILLI-M NA REMARK 280 PROPIONATE, NA CACODYLATE, BIS-TRIS-PROPANE (PCTP 50% ACID/50% REMARK 280 BASIC) PH 7.0 + 0.001 M INHIBITOR DC27., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 109.03333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.51667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 54.51667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.03333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 509 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 517 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 490 O HOH A 515 5445 2.17 REMARK 500 O HOH A 472 O HOH A 493 5555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 173 -139.55 50.95 REMARK 500 ASP A 185 -158.87 58.53 REMARK 500 ASP A 235 -164.13 -105.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 305 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 131 OD2 REMARK 620 2 ASP A 206 O 166.6 REMARK 620 3 ASP A 206 OD1 98.7 77.0 REMARK 620 4 GLU A 208 O 83.8 87.0 118.0 REMARK 620 5 HOH A 451 O 83.0 106.9 152.2 89.8 REMARK 620 6 HOH A 476 O 128.7 63.9 83.2 140.1 74.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 304 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 165 O REMARK 620 2 GLY A 197 O 170.9 REMARK 620 3 GLN A 199 O 103.0 84.8 REMARK 620 4 ASP A 201 OD1 87.3 96.3 98.5 REMARK 620 5 HOH A 420 O 91.0 80.3 159.3 97.4 REMARK 620 6 HOH A 424 O 83.9 92.9 80.0 170.4 86.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 175 NE2 REMARK 620 2 ASP A 177 OD2 112.7 REMARK 620 3 HIS A 190 NE2 111.4 113.5 REMARK 620 4 HIS A 203 ND1 110.6 95.6 112.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 182 OD1 REMARK 620 2 GLY A 183 O 88.9 REMARK 620 3 ASP A 185 O 86.1 85.4 REMARK 620 4 LEU A 187 O 93.0 177.2 92.6 REMARK 620 5 ASP A 205 OD2 91.9 90.5 175.4 91.6 REMARK 620 6 GLU A 208 OE2 169.0 91.1 82.9 86.6 99.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 226 NE2 REMARK 620 2 HIS A 230 NE2 100.3 REMARK 620 3 HIS A 236 NE2 120.7 99.4 REMARK 620 4 H27 A 306 O98 122.3 122.2 91.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H27 A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IOL RELATED DB: PDB REMARK 900 MMP-12 WITH THE SAME LIGAND. REMARK 900 RELATED ID: 4HMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MMP-9 CATALYTIC DOMAIN WITH A RELATED REMARK 900 CARBOXYLATE BASED INHIBITOR DBREF 5I12 A 113 216 UNP P14780 MMP9_HUMAN 113 216 DBREF 5I12 A 217 269 UNP P14780 MMP9_HUMAN 392 444 SEQRES 1 A 157 ASP LEU LYS TRP HIS HIS HIS ASN ILE THR TYR TRP ILE SEQRES 2 A 157 GLN ASN TYR SER GLU ASP LEU PRO ARG ALA VAL ILE ASP SEQRES 3 A 157 ASP ALA PHE ALA ARG ALA PHE ALA LEU TRP SER ALA VAL SEQRES 4 A 157 THR PRO LEU THR PHE THR ARG VAL TYR SER ARG ASP ALA SEQRES 5 A 157 ASP ILE VAL ILE GLN PHE GLY VAL ALA GLU HIS GLY ASP SEQRES 6 A 157 GLY TYR PRO PHE ASP GLY LYS ASP GLY LEU LEU ALA HIS SEQRES 7 A 157 ALA PHE PRO PRO GLY PRO GLY ILE GLN GLY ASP ALA HIS SEQRES 8 A 157 PHE ASP ASP ASP GLU LEU TRP SER LEU GLY LYS GLY VAL SEQRES 9 A 157 GLY TYR SER LEU PHE LEU VAL ALA ALA HIS GLU PHE GLY SEQRES 10 A 157 HIS ALA LEU GLY LEU ASP HIS SER SER VAL PRO GLU ALA SEQRES 11 A 157 LEU MET TYR PRO MET TYR ARG PHE THR GLU GLY PRO PRO SEQRES 12 A 157 LEU HIS LYS ASP ASP VAL ASN GLY ILE ARG HIS LEU TYR SEQRES 13 A 157 GLY HET ZN A 301 1 HET ZN A 302 1 HET CA A 303 1 HET CA A 304 1 HET CA A 305 1 HET H27 A 306 52 HET EDO A 307 4 HET DMS A 308 4 HET GOL A 309 6 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM H27 (2R)-2-[{(E)-2-[({(2R,3R,4R,5S,6R)-3-(ACETYLAMINO)-4,5- HETNAM 2 H27 BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]TETRAHYDRO-2H- HETNAM 3 H27 PYRAN-2-YL}CARBAMOTHIOYL)AMINO]ETHENYL}(BIPHENYL-4- HETNAM 4 H27 YLSULFONYL)AMINO]-3-METHYLBUTANOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CA 3(CA 2+) FORMUL 7 H27 C34 H42 N4 O12 S2 FORMUL 8 EDO C2 H6 O2 FORMUL 9 DMS C2 H6 O S FORMUL 10 GOL C3 H8 O3 FORMUL 11 HOH *117(H2 O) HELIX 1 AA1 PRO A 133 ALA A 150 1 18 HELIX 2 AA2 LEU A 220 LEU A 232 1 13 HELIX 3 AA3 HIS A 257 GLY A 269 1 13 SHEET 1 AA1 5 THR A 155 ARG A 158 0 SHEET 2 AA1 5 ASN A 120 ILE A 125 1 N ILE A 121 O THR A 157 SHEET 3 AA1 5 ILE A 166 GLY A 171 1 O ILE A 168 N TRP A 124 SHEET 4 AA1 5 ALA A 202 ASP A 205 1 O PHE A 204 N GLN A 169 SHEET 5 AA1 5 ALA A 189 ALA A 191 -1 N HIS A 190 O HIS A 203 SHEET 1 AA2 2 TRP A 210 SER A 211 0 SHEET 2 AA2 2 TYR A 218 SER A 219 1 O TYR A 218 N SER A 211 LINK OD2 ASP A 131 CA CA A 305 1555 1555 2.39 LINK O ASP A 165 CA CA A 304 1555 1555 2.39 LINK NE2 HIS A 175 ZN ZN A 302 1555 1555 2.08 LINK OD2 ASP A 177 ZN ZN A 302 1555 1555 1.96 LINK OD1 ASP A 182 CA CA A 303 1555 1555 2.35 LINK O GLY A 183 CA CA A 303 1555 1555 2.29 LINK O ASP A 185 CA CA A 303 1555 1555 2.33 LINK O LEU A 187 CA CA A 303 1555 1555 2.28 LINK NE2 HIS A 190 ZN ZN A 302 1555 1555 2.07 LINK O GLY A 197 CA CA A 304 1555 1555 2.32 LINK O GLN A 199 CA CA A 304 1555 1555 2.35 LINK OD1 ASP A 201 CA CA A 304 1555 1555 2.34 LINK ND1 HIS A 203 ZN ZN A 302 1555 1555 2.05 LINK OD2 ASP A 205 CA CA A 303 1555 1555 2.35 LINK O ASP A 206 CA CA A 305 1555 1555 2.36 LINK OD1 ASP A 206 CA CA A 305 1555 1555 2.42 LINK OE2 GLU A 208 CA CA A 303 1555 1555 2.30 LINK O GLU A 208 CA CA A 305 1555 1555 2.32 LINK NE2 HIS A 226 ZN ZN A 301 1555 1555 2.00 LINK NE2 HIS A 230 ZN ZN A 301 1555 1555 2.02 LINK NE2 HIS A 236 ZN ZN A 301 1555 1555 2.13 LINK ZN ZN A 301 O98 H27 A 306 1555 1555 1.90 LINK CA CA A 304 O HOH A 420 1555 1555 2.44 LINK CA CA A 304 O HOH A 424 1555 1555 2.34 LINK CA CA A 305 O HOH A 451 1555 1555 2.32 LINK CA CA A 305 O HOH A 476 1555 1555 3.10 SITE 1 AC1 4 HIS A 226 HIS A 230 HIS A 236 H27 A 306 SITE 1 AC2 4 HIS A 175 ASP A 177 HIS A 190 HIS A 203 SITE 1 AC3 6 ASP A 182 GLY A 183 ASP A 185 LEU A 187 SITE 2 AC3 6 ASP A 205 GLU A 208 SITE 1 AC4 6 ASP A 165 GLY A 197 GLN A 199 ASP A 201 SITE 2 AC4 6 HOH A 420 HOH A 424 SITE 1 AC5 5 ASP A 131 ASP A 206 GLU A 208 HOH A 451 SITE 2 AC5 5 HOH A 476 SITE 1 AC6 18 LEU A 187 LEU A 188 ALA A 189 LYS A 214 SITE 2 AC6 18 LEU A 222 HIS A 226 GLU A 227 HIS A 230 SITE 3 AC6 18 HIS A 236 LEU A 243 TYR A 245 PRO A 246 SITE 4 AC6 18 MET A 247 ASN A 262 HIS A 266 ZN A 301 SITE 5 AC6 18 GOL A 309 HOH A 404 SITE 1 AC7 5 ASP A 113 LYS A 115 TRP A 116 HIS A 117 SITE 2 AC7 5 HIS A 118 SITE 1 AC8 2 TYR A 179 ALA A 191 SITE 1 AC9 6 PRO A 240 GLU A 241 ALA A 242 ARG A 249 SITE 2 AC9 6 THR A 251 H27 A 306 CRYST1 39.560 39.560 163.550 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025278 0.014594 0.000000 0.00000 SCALE2 0.000000 0.029189 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006114 0.00000